Mixed amphetamine salts-extended release for ADHD adults with cocaine use disorder

Aims: Methylphenidate has produced modest effects in treating ADHD in those with substance use disorders, and the impact of treating ADHD on reducing substance use remains unclear. To date, there have been no controlled published studies evaluating amphetamine analogues. The purpose of this 13 week double-blind, placebo-controlled, two-site trial was to evaluate the efficacy of two robust doses of mixed amphetamine salts-extended release (MAS-ER; Adderall-XR®) as a treatment for ADHD and cocaine dependence.

Source: Drug and Alcohol Dependence - December 18, 2014 Category: Addiction Authors: Frances R. Levin, John J. Mariani, Amy Mahony, Daniel J. Brooks, Lynn Eberly, Yun Bai, Sheila Specker, Marc Mooney, Edward V. Nunes, John Grabowski Source Type: research